Agents Classified by the IARC Monographs, Volumes 1–103
Acetaldehyde associated with consumption of alcoholic
000313-67-7 (NB: Overall evaluation upgraded to Group 1 based on
000313-67-7 Aristolochic acid, plants containing
007440-38-2 Arsenic and inorganic arsenic compounds
001332-21-4 013768-00-8 Asbestos (all forms, including actinolite, amosite, 012172-73-5 anthophyllite, chrysotile, crocidolite, tremolite)
017068-78-9 (NB: Mineral substances (e.g. talc or vermiculite) that
012001-29-5 contain asbestos should also be regarded as 012001-28-4 carcinogenic to humans.) 014567-73-8
(NB: Overall evaluation upgraded to Group 1 based on
000050-32-8 (NB: Overall evaluation upgraded to Group 1 based on
007440-41-7 Beryllium and beryllium compounds
000542-88-1 Bis(chloromethyl)ether; chloromethyl methyl ether
007440-43-9 Cadmium and cadmium compounds
Clonorchis sinensis (infection with)
Coal, indoor emissions from household combustion of
Estrogen-progestogen menopausal therapy (combined)
Estrogen-progestogen oral contraceptives (combined)
(NB: There is also convincing evidence in humans that
these agents confer a protective effect against cancer in the endometrium and ovary)
000064-17-5 Ethanol in alcoholic beverages
000075-21-8 (NB: Overall evaluation upgraded to Group 1 based on
033419-42-0 (NB: Overall evaluation upgraded to Group 1 based on
033419-42-0 015663-27-1 Etoposide in combination with cisplatin and bleomycin
Fission products, including strontium-90
Helicobacter pylori (infection with)
Hepatitis B virus (chronic infection with)
Hepatitis C virus (chronic infection with)
Human immunodeficiency virus type 1 (infection with)
Human papillomavirus types 16, 18, 31, 33, 35, 39, 45,
(NB: The HPV types that have been classified as
carcinogenic to humans can differ by an order of magnitude in risk for cervical cancer)
Iron and steel founding (occupational exposure during)
Isopropyl alcohol manufacture using strong acids
Methoxsalen (8-methoxypsoralen) plus ultraviolet A
4,4'-Methylenebis(2-chloroaniline) (MOCA)
000101-14-4 (NB: Overall evaluation upgraded to Group 1 based on
Mineral oils, untreated or mildly treated
MOPP and other combined chemotherapy including
(NB: Overall evaluation upgraded to Group 1 with
supporting evidence from other relevant data)
N'-Nitrosonornicotine (NNN) and 4-(N-
016543-55-8 Nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK)
064091-91-4 (NB: Overall evaluation upgraded to Group 1 based on
mechanistic and other relevant data)Opisthorchis viverrini (infection with)
3,4,5,3’,4’-Pentachlorobiphenyl (PCB-126)
057465-28-8 (NB: Overall evaluation upgraded to Group 1 based on
057117-31-4 (NB: Overall evaluation upgraded to Group 1 based on
000062-44-2 (NB: Overall evaluation upgraded to Group 1 with
supporting evidence from other relevant data)
Phenacetin, analgesic mixtures containing
Radionuclides, alpha-particle-emitting, internally
(NB: Specific radionuclides for which there is sufficient evidence in humans are also listed individually as Group 1 agents)
Radionuclides, beta-particle-emitting, internally deposited
(NB: Specific radionuclides for which there is
evidence in humans are also listed individually as Group 1 agents)
013233-32-4 Radium-224 and its decay products
013982-63-3 Radium-226 and its decay products
015262-20-1 Radium-228 and its decay products
010043-92-2 Radon-222 and its decay products
Schistosoma haematobium (infection with)
Semustine [1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-
014808-60-7 Silica dust, crystalline, in the form of quartz or cristobalite
Soot (as found in occupational exposure of chimney
(NB: There is also conclusive evidence that tamoxifen
reduces the risk of contralateral breast cancer in breast cancer patients)
001746-01-6 2,3,7,8-Tetrachlorodibenzo-para-dioxin 1
007440-29-1 Thorium-232 and its decay products
Ultraviolet radiation (wavelengths 100-400 nm,
000079-06-1 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
023214-92-8 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
Art glass, glass containers and pressed ware
000320-67-2 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
Biomass fuel (primarily wood), indoor emissions from
000154-93-8 Bischloroethyl nitrosourea (BCNU)
064742-93-4 Bitumens, oxidized, and their emissions during roofing
002425-06-1 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
000056-75-7 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
000098-87-3 alpha-Chlorinated toluenes (benzal chloride,
000098-07-7 benzotrichloride, benzyl chloride) and benzoyl chloride
1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)
013010-47-4 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
000095-69-2 4-Chloro-ortho-toluidine 2A
054749-90-5 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
015663-27-1 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
007440-48-4 Cobalt metal with tungsten carbide
027208-37-3 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
000224-42-0 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
000053-70-3 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
000191-30-0 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
000064-67-5 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
000079-44-7 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
000540-73-8 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
000077-78-1 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
000106-89-8 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
000106-93-4 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
000759-73-9 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
Frying, emissions from high-temperature
000556-52-5 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
Hairdresser or barber (occupational exposure as a)
(NB: Overall evaluation upgraded to Group 2A)
IQ (2-Amino-3-methylimidazo[4,5-f]quinoline)
076180-96-6 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
000484-20-8 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
000066-27-3 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
N-Methyl-N´-nitro-N-nitrosoguanidine (MNNG)
000070-25-7 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
000684-93-5 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
Nitrate or nitrite (ingested) under conditions that result in
000055-18-5 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
000062-75-9 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
000088-72-2 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
Non-arsenical insecticides (occupational exposures in
Petroleum refining (occupational exposures in)
000366-70-1 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
Shiftwork that involves circadian disruption
000096-09-3 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
029767-20-2 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
000127-18-4 Tetrachloroethylene (Perchloroethylene)
000126-72-7 (NB: Overall evaluation upgraded to Group 2A with
supporting evidence from other relevant data)
(NB: (1) Overall evaluation upgraded to Group 2A based on mechanistic and other relevant data;
(2) For practical purposes, vinyl bromide should be
considered to act similarly to the human carcinogen vinyl chloride.)
(NB: (1) Overall evaluation upgraded to Group 2A based on mechanistic and other relevant data;
(2) For practical purposes, vinyl fluoride should be considered to act similarly to the human carcinogen vinyl chloride.)
026148-68-5 A-alpha-C (2-Amino-9H-pyrido[2,3-b]indole)
003688-53-7 AF-2 [2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide]
000097-56-3 ortho-Aminoazotoluene
000081-49-2 1-Amino-2,4-dibromoanthraquinone
000712-68-5 2-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole
000151-56-4 (NB: Overall evaluation upgraded to Group 2B with
supporting evidence from other relevant data)
000202-33-5 (NB: Overall evaluation upgraded to Group 2B with
supporting mechanistic and other relevant data)
000205-99-2 Benzo[b]fluoranthene 2B
000205-82-3 Benzo[j]fluoranthene 2B
000207-08-9 Benzo[k]fluoranthene 2B
000195-19-7 (NB: Overall evaluation upgraded to Group 2B with
supporting evidence from other relevant data)
003296-90-0 2,2-Bis(bromomethyl)propane-1,3-diol
Bitumens, extracts of steam-refined and air-refined
008052-42-4 (see Bitumens, oxidized; Bitumens, hard; Bitumens,
Bitumens, hard, and their emissions during mastic
008052-42-4 Bitumens, straight-run, and their emissions during road-
011056-06-7 (NB: Overall evaluation upgraded to Group 2B with
supporting evidence from other relevant data)
005589-96-8 Bromochloroacetic acid
025013-16-5 Butylated hydroxyanisole (BHA)
053973-98-1 Carrageenan, degraded (Poligeenan)
Chlorinated paraffins of average carbon chain length C12
and average degree of chlorination approximately 60%
000106-47-8 para-Chloroaniline 2B
077439-76-0 3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone 2B
000095-83-0 4-Chloro-ortho-phenylenediamine
007440-48-4 Cobalt metal without tungsten carbide
010026-24-1 Cobalt sulfate and other soluble cobalt(II) salts
068603-42-9 Coconut oil diethanolamine condensate
(NB: There is some evidence of an inverse relationship
between coffee drinking and cancer of the large bowel;
coffee drinking could not be classified as to its carcinogenicity to other organs)
000117-10-2 Dantron (Chrysazin; 1,8-Dihydroxyanthraquinone)
000050-29-3 DDT (4,4'-Dichlorodiphenyltrichloroethane)
000613-35-4 N,N'-Diacetylbenzidine
000226-36-8 Dibenz[a,h]acridine 2B
000224-53-3 (NB: Overall evaluation upgraded to Group 2B with
supporting evidence from other relevant data)
000194-59-2 7H-Dibenzo[c,g]carbazole 2B
000189-64-0 Dibenzo[a,h]pyrene 2B
000189-55-9 Dibenzo[a,i]pyrene 2B
000106-46-7 para-Dichlorobenzene 2B
028434-86-8 3,3'-Dichloro-4,4'-diaminodiphenyl ether
000075-09-2 Dichloromethane (Methylene chloride)
000542-75-6 1,3-Dichloropropene (technical-grade)
(NB: Overall evaluation upgraded to Group 2B with
supporting evidence from other relevant data)
000119-90-4 3,3'-Dimethoxybenzidine (ortho-Dianisidine)
000060-11-7 para-Dimethylaminoazobenzene
025962-77-0 trans-2-[(Dimethylamino)methylimino]-5-[2-(5-nitro-2-
000087-62-7 2,6-Dimethylaniline (2,6-Xylidine)
000119-93-7 3,3'-Dimethylbenzidine (ortho-Tolidine)
Dry cleaning (occupational exposures in)
000106-88-7 (NB: Overall evaluation upgraded to Group 2B with
supporting evidence from other relevant data)
Firefighter (occupational exposure as a)
003570-75-0 2-(2-Formylhydrazino)-4-(5-nitro-2-furyl)thiazole
116355-83-0 Fusarium moniliforme, toxins derived from (fumonisin B1,
(NB: Overall evaluation upgraded to Group 2B with
supporting evidence from other relevant data)
067730-10-3 Glu-P-2 (2-Aminodipyrido[1,2-a:3',2'-d]imidazole)
Human immunodeficiency virus type 2 (infection with)
Human papillomavirus types 5 and 8 (in patients with
Human papillomavirus types 26, 53, 66, 67, 70, 73, 82
Human papillomavirus types 30, 34, 69, 85, 97
(NB: Classified by phylogenetic analogy to the HPV
genus alpha types classified in Group 1)
000193-39-5 Indeno[1,2,3-cd]pyrene 2B
Magnetic fields, extremely low-frequency
068006-83-7 MeA-alpha-C (2-Amino-3-methyl-9H-pyrido[2,3-b]indole)
077094-11-2 MeIQ (2-Amino-3,4-dimethylimidazo[4,5-f]quinoline) 2B
077500-04-0 MeIQx (2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline) 2B
000075-55-8 2-Methylaziridine (Propyleneimine)
000838-88-0 4,4'-Methylene bis(2-methylaniline)
000129-15-7 2-Methyl-1-nitroanthraquinone (uncertain purity)
000615-53-2 N-Methyl-N-nitrosourethane
000101-61-1 Michler’s base [4,4-methylenebis(N,N-dimethyl)-
000090-94-8 Michler’s ketone [4,4-Bis(dimethylamino)benzophenone]
000096-24-2 3-Monochloro-1,2-propanediol
5-(Morpholinomethyl)-3-[(5-nitrofurfurylidene)amino]-2-
000555-84-0 1-[(5-Nitrofurfurylidene)amino]-2-imidazolidinone
000531-82-8 N-[4-(5-Nitro-2-furyl)-2-thiazolyl]acetamide
000126-85-2 Nitrogen mustard N-oxide
000924-16-3 N-Nitrosodi-n-butylamine
001116-54-7 N-Nitrosodiethanolamine
000621-64-7 N-Nitrosodi-n-propylamine
060153-49-3 3-(N-Nitrosomethylamino)propionitrile
010595-95-6 N-Nitrosomethylethylamine
004549-40-0 N-Nitrosomethylvinylamine
000059-89-2 N-Nitrosomorpholine
000100-75-4 N-Nitrosopiperidine
000930-55-2 N-Nitrosopyrrolidine
013256-22-9 N-Nitrososarcosine
012174-11-7 Palygorskite (Attapulgite) (long fibres, > 5 micrometres)
000794-93-4 Panfuran S (containing dihydroxymethylfuratrizine)
Pickled vegetables (traditional in Asia)
000136-40-3 Phenazopyridine hydrochloride
000063-92-3 Phenoxybenzamine hydrochloride
105650-23-5 PhIP (2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) 2B
Polychlorophenols and their sodium salts (mixed
Printing processes (occupational exposures in)
Radiofrequency electromagnetic fields1 2B
Schistosoma japonicum (infection with)
000132-27-4 Sodium ortho-phenylphenate 2B
Special-purpose fibres such as E-glass and '475' glass
1 Includes radiofrequency electromagnetic fields from wireless phones
Surgical implants and other foreign bodies:
- Polymeric implants prepared as thin smooth film (with the exception of poly(glycolic acid))
- Metallic implants prepared as thin smooth films
- Implanted foreign bodies of metallic cobalt, metallic nickel and an alloy powder containing 66-67% nickel, 13-16% chromium and 7% iron
014807-96-6 Talc-based body powder (perineal use of)
Textile manufacturing industry (work in)
008001-35-2 Toxaphene (Polychlorinated camphenes)
000817-09-4 Trichlormethine (Trimustine hydrochloride)
062450-06-0 Trp-P-1 (3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole)
062450-07-1 Trp-P-2 (3-Amino-1-methyl-5H-pyrido[4,3-b]indole)
000106-87-6 4-Vinylcyclohexene diepoxide
(NB: Volume 100D concluded that there is sufficient evidence for ocular melanoma in welders)
025732-74-5 Acepyrene (3,4-dihydrocyclopenta[cd]pyrene) 3
Acrylonitrile-butadiene-styrene copolymers
000150-13-0 para-Aminobenzoic acid
000082-28-0 1-Amino-2-methylanthraquinone
000061-82-5 (NB: Overall evaluation downgraded to Group 3 with
supporting evidence from other relevant data)
000523-50-2 Angelicin plus ultraviolet A radiation
Arsenobetaine and other organic arsenic compounds that
001912-24-9 (NB: Overall evaluation downgraded to Group 3 with
supporting evidence from other relevant data)
000202-94-8 11H-Benz[bc]aceanthrylene 3
000211-91-6 Benz[l]aceanthrylene 3
000203-33-8 Benzo[a]fluoranthene 3
000203-12-3 Benzo[ghi]fluoranthene 3
000239-35-0 Benzo[b]naphtho[2,1-d]thiophene 3
000105-11-3 para-Benzoquinone dioxime
002168-68-5 Bis(1-aziridinyl)morpholinophosphine sulfide
000111-44-4 Bis(2-chloroethyl)ether
013483-18-6 1,2-Bis(chloromethoxy)ethane
056894-91-8 1,4-Bis(chloromethoxymethyl)benzene
000108-60-1 Bis(2-chloro-1-methylethyl)ether
002386-90-5 Bis(2,3-epoxycyclopentyl)ether
001675-54-3 Bisphenol A diglycidyl ether (Araldite ) 3
Bitumens, steam-refined, cracking-residue and air-refined
008052-42-4 (see Bitumens, oxidized; Bitumens, hard; Bitumens,
003844-45-9 Brilliant Blue FCF, disodium salt
057018-52-7 1-tert-Butoxypropan-2-ol 3
000128-37-0 Butylated hydroxytoluene (BHT)
000088-73-3 000121-73-3 Chloronitrobenzenes 3
000100-00-5 005131-60-2 4-Chloro-meta-phenylenediamine
000095-79-4 5-Chloro-ortho-toluidine 3
000075-88-7 2-Chloro-1,1,1-trifluoroethane
000102-50-1 meta-Cresidine
000139-05-9 Cyclamates (sodium cyclamate)
000202-98-2 4H-Cyclopenta[def]chrysene 3
007099-43-6 5,6-Cyclopenteno-1,2-benzanthracene
001163-19-5 Decabromodiphenyl oxide
000083-63-6 Diacetylaminoazotoluene
000215-58-7 Dibenz[a,c]anthracene 3
000224-41-9 Dibenz[a,j]anthracene 3
000262-12-4 Dibenzo-para-dioxin 3
005385-75-1 Dibenzo[a,e]fluoranthene 3
000207-83-0 13H-Dibenzo[a,g]fluorene 3
000192-47-2 Dibenzo[h,rst]pentaphene 3
000541-73-1 meta-Dichlorobenzene 3
000095-50-1 ortho-Dichlorobenzene 3
000110-57-6 trans-1,4-Dichlorobutene
000609-20-1 2,6-Dichloro-para-phenylenediamine
000105-55-5 N,N'-Diethylthiourea 3
000794-93-4 Dihydroxymethylfuratrizine (see also Panfuran S)
000091-93-0 3,3'-Dimethoxybenzidine-4,4'-diisocyanate
000140-56-7 para-Dimethylaminoazobenzenediazo sodium sulfonate
022975-76-4 4,4'-Dimethylangelicin plus ultraviolet A radiation
004063-41-6 4,5'-Dimethylangelicin plus ultraviolet A radiation
000121-69-7 N,N-Dimethylaniline 3
000101-25-7 Dinitrosopentamethylenetetramine
Electric fields, extremely low-frequency
3,4-Epoxy-6-methylcyclohexylmethyl-3,4-epoxy-6-
002443-39-2 cis-9,10-Epoxystearic acid
000096-45-7 (NB: Overall evaluation downgraded to Group 3 with
supporting evidence from other relevant data)
Flat-glass and specialty glass (manufacture of)
016984-48-8 Fluorides (inorganic, used in drinking-water)
Fusarium graminearum, F. culmorum,and F. crookwellense, toxins derived from (zearalenone,
deoxynivalenol, nivalenol, and fusarenone X)
Fusarium sporotrichioides, toxins derived from (T-2 toxin)
Hair colouring products (personal use of)
Human papillomavirus genus beta (except types 5 and 8)
Human T-cell lymphotropic virus type II
001338-16-5 Iron sorbitol-citric acid complex
000054-85-3 Isonicotinic acid hydrazide (Isoniazid)
(NB: Organic lead compounds are metabolized at least in part, to ionic lead both in humans and animals. To the
extent that ionic lead, generated from organic lead, is present in the body, it will be expected to exert the toxicities associated with inorganic lead.)
005989-27-5 (NB: Overall evaluation downgraded to Group 3 with
supporting evidence from other relevant data)
Lumber and sawmill industries (including logging)
000551-74-6 Mannomustine dihydrochloride
000108-78-1 (NB: Overall evaluation downgraded to Group 3 with
supporting evidence from other relevant data)
007439-97-6 Mercury and inorganic mercury compounds
073459-03-7 5-Methylangelicin plus ultraviolet A radiation
001634-04-4 Methyl tert-butyl ether
000099-80-9 N-Methyl-N,4-dinitrosoaniline
000101-68-8 4,4'-Methylenediphenyl diisocyanate
090456-67-0 N-Methylolacrylamide 3
085878-63-3 7-Methylpyrido[3,4-c]psoralen
003173-72-6 1,5-Naphthalene diisocyanate
111189-32-3 Naphtho[1,2-b]fluoranthene 3
000203-20-3 Naphtho[2,1-a]fluoranthene 3
000193-09-9 Naphtho[2,3-e]pyrene 3
000086-88-4 1-Naphthylthiourea (ANTU)
000099-59-2 5-Nitro-ortho-anisidine
020268-51-3 7-Nitrobenz[a]anthracene 3
063041-90-7 6-Nitrobenzo[a]pyrene 3
037620-20-5 N'-Nitrosoanabasine (NAB)
071267-22-6 N'-Nitrosoanatabine (NAT)
000086-30-6 N-Nitrosodiphenylamine
000156-10-5 para-Nitrosodiphenylamine
055557-02-3 N-Nitrosoguvacoline 3
030310-80-6 N-Nitrosohydroxyproline
085502-23-4 3-(N-Nitrosomethylamino)propionaldehyde 3
007519-36-0 N-Nitrosoproline
000099-99-0 000099-55-8 5-Nitro-ortho-toluidine 3
Opisthorchis felineus (infection with)
Paint manufacture (occupational exposure in)
012174-11-7 Palygorskite (Attapulgite)(short fibres, < 5 micrometres)
000108-45-2 meta-Phenylenediamine
000106-50-3 para-Phenylenediamine
000135-88-6 N-Phenyl-2-naphthylamine
009016-87-9 Polymethylene polyphenyl isocyanate
023746-34-1 Potassium bis(2-hydroxyethyl)dithiocarbamate
085878-62-2 Pyrido[3,4-c]psoralen
000082-68-8 Quintozene (Pentachloronitrobenzene)
000081-07-2 (NB: Overall evaluation downgraded to Group 3 with
supporting evidence from other relevant data)
Schistosoma mansoni (infection with)
007782-49-2 Selenium and selenium compounds
000148-18-5 Sodium diethyldithiocarbamate
009003-54-7 Styrene-acrylonitrile copolymers
009003-55-8 Styrene-butadiene copolymers
000127-69-5 Sulfafurazole (Sulfisoxazole)
000057-68-1 (NB: Overall evaluation downgraded to Group 3 with
supporting evidence from other relevant data)
Surgical implants and other foreign bodies:
- Organic polymeric materials (as a group) - Orthopaedic implants of complex composition - Cardiac pacemakers - Silicone breast implants
- Implanted foreign bodies of metallic chromium or
titanium and of cobalt-based, chromium-based and titanium-based alloys, stainless steel and depleted uranium - Dental materials - Ceramic implants
014807-96-6 Talc not containing asbestos or asbestiform fibres
008001-50-1 Terpene polychlorinates (Strobane®)
015721-02-5 2,2',5,5'-Tetrachlorobenzidine
Tetrakis(hydroxymethyl)phosphonium salts
001954-28-5 Triethylene glycol diglycidyl ether
090370-29-9 4,4',6-Trimethylangelicin plus ultraviolet A radiation
000068-76-8 Tris(aziridinyl)-para-benzoquinone (Triaziquone)
000545-55-1 Tris(1-aziridinyl)phosphine oxide
000051-18-3 2,4,6-Tris(1-aziridinyl)-s-triazine
000115-96-8 Tris(2-chloroethyl) phosphate
038571-73-2 1,2,3-Tris(chloromethoxy)propane
000057-39-6 Tris(2-methyl-1-aziridinyl)phosphine oxide
009003-22-9 Vinyl chloride-vinyl acetate copolymers
009011-06-7 Vinylidene chloride-vinyl chloride copolymers
000088-12-0 N-Vinyl-2-pyrrolidone
Zeolites other than erionite (clinoptilolite,
001318-02-1 phillipsite,mordenite, non-fibrous Japanese zeolite,
000103-90-2 Acetaminophen (see Paracetamol)
012174-11-7 Attapulgite (see Palygorskite)
000494-03-1 N,N-Bis(2-chloroethyl)-2-naphthylamine (see
Bis(2-ethylhexyl) phthalate (see Di(2-ethylhexyl)
Boot and shoe manufacture and repair (see Leather dust,
000055-98-1 1,4-Butanediol dimethanesulfonate (see Busulfan)
1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea
Chloromethyl methyl ether (see Bis(chloromethyl)ether;
001937-37-7 CI Direct Black 38 (see Benzidine, dyes metabolized to)
002602-46-2 CI Direct Blue 6 (see Benzidine, dyes metabolized to)
016071-86-6 CI Direct Brown 95 (see Benzidine, dyes metabolized to)
059865-13-3 Ciclosporin (see Cyclosporine)
008007-45-2 Coal tars (see Coal-tar distillation)
Continuous glass filament (see Glass filament)
Diesel engine exhaust (see Engine exhaust, diesel)
Dyes metabolized to benzidine (see Benzidine, dyes
Foreign bodies (see Surgical implants and other foreign
Furniture and cabinet making (see Wood dust)
Gallium arsenide (see Arsenic and inorganic arsenic
Gamma-Radiation (see X- and Gamma-Radiation)
Gasoline engine exhaust (see Engine exhaust, gasoline)
Household combustion of biomass fuel (see Biomass
fuel, indoor emissions from household combustion of)
Household combustion of coal (see Coal, indoor
Human herpesvirus type 4 (see Epstein-Barr virus)
Human herpesvirus type 8 (see Kaposi sarcoma
Involuntary smoking (see Tobacco smoke, second-hand)
010043-66-0 Iodine-131 (see Radioiodines)
000505-60-2 Mustard gas (see Sulfur mustard)
Oral contraceptives, combined estrogen-progestogen
(see Estrogen-progestogen oral contraceptives)
000523-44-4 Orange I (see CI Acid Orange 20)
Paving and roofing with coal-tar pitch (see Coal-tar pitch)
000087-86-5 Pentachlorophenol (see Polychlorophenols)
053973-98-1 Poligeenan (see Carrageenan, degraded)
Strong-inorganic-acid mists containing sulfuric acid (see
010098-97-2 Strontium-90 (see Fission products)
Sunlamps and sunbeds (see Ultraviolet-emitting tanning
014807-96-6 Talc containing asbestiform fibres (see Asbestos)
012070-12-1 Tungsten carbide with cobalt metal (see Cobalt metal
Wood smoke (see Biomass fuel, indoor emissions from
Last update: 22 February 2012
Lauren Herr 1148 Jaland Ct, San Jose, CA 95120 • 408.691.0079 herr.lauren@gmail.com • http://lauren.herr.cc EDUCATION Pepperdine University, Malibu, CA Fall 2009-Spring 2013 Major in Media Production; Minor in Multimedia Design Graduated April 2013 Activities: On-Air Graphics Designer and Operator for weekly live news television show, Newswaves32 (2012-2013), Fashion Bl
Joint analysis of two Phase II studies with Desmoteplase presented at the European Stroke Conference Confirmatory study DIAS-2 started to confirm 3-9 hour treatment time window Aachen, Bologna, 30 May 2005 – The joint analysis of DIAS and DEDAS, two Phase II studies sponsored by PAION that examined the investigational novel plasminogen activator Desmoteplase in the treatment of acute isc